Cargando…
Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
Autores principales: | Hayes, Kaleen N., Baschant, Ulrike, Hauser, Barbara, Burden, Andrea M., Winter, Elizabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964402/ https://www.ncbi.nlm.nih.gov/pubmed/35370960 http://dx.doi.org/10.3389/fendo.2022.877512 |
Ejemplares similares
-
When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
por: Hayes, Kaleen N., et al.
Publicado: (2021) -
Editorial: Glucocorticoid and bone: Friend or foe
por: Baschant, Ulrike, et al.
Publicado: (2022) -
Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study
por: Hayes, Kaleen N, et al.
Publicado: (2022) -
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
por: Gado, Manuel, et al.
Publicado: (2022) -
Antiosteoporosis and bone protective effect of dieckol against glucocorticoid-induced osteoporosis in rats
por: Wang, Hao, et al.
Publicado: (2022)